New Insights into Monoclonal B-Cell Lymphocytosis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kalpadakis, Christina ^a   Pangalis, Gerassimos A ^b   Sachanas, Sotirios ^b   Vassilakopoulos, Theodoros P ^c   Kyriakaki, Stavroula ^a   Korkolopoulou, Penelope ^c   Koulieris, Efstathios ^b   Moschogiannis, Maria ^b   Yiakoumis, Xanthi ^b   Tsirkinidis, Pantelis ^b,d   Kyrtsonis, Marie Christine ^c   Levidou, Georgia ^c   Papadaki, Helen A ^a   Panayiotidis, Panayiotis ^c   Angelopoulou, Maria K ^c  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b ATHENS MEDICAL CENTER   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d 401 Military Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN;

ARTICLE; BONE MARROW; CYTOGENETICS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MARGINAL ZONE LYMPHOMA; MONOCLONAL B CELL LYMPHOCYTOSIS; PREVALENCE; RISK FACTOR; ADULT; B LYMPHOCYTE; IMMUNOLOGY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; PATHOLOGY;

ADULT; ANTIGENS, CD5; B-LYMPHOCYTES; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; LYMPHOCYTOSIS;

EID: 84930801311     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/258917     Document Type: Article

References (65)

1. T. Han, H. Ozer, M. Gavigan et al., "Benign monoclonal B cell lymphocytosis. A benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients, " Blood, vol. 64, no. 1, pp. 244-252, 1984.
2. E. Kimby, H. Mellstedt, M. Bjorkholm, and G. Holm, "Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis undetermined significance, " European Journal of Haematology, vol. 43, no. 5, pp. 452-459, 1989.
3. W. G. Nieto, J. Almeida, A. Romero et al., "Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach, " Blood, vol. 114, no. 1, pp. 33-37, 2009.
4. A. C. Rawstron, M. J. Green, A. Kuzmicki et al., "Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3. 5%of adults with normal blood counts, " Blood, vol. 100, no. 2, pp. 635-639, 2002.
5. P. Ghia, G. Prato, C. Scielzo et al., "Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly, " Blood, vol. 103, no. 6, pp. 2337-2342, 2004.
6. L. Scarfo, A. Dagklis, C. Scielzo, C. Fazi, and P. Ghia, "CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?" Seminars in Cancer Biology, vol. 20, no. 6, pp. 384-390, 2010.
7. J. Almeida, W. G. Nieto, C. Teodosio et al., "CLL-like Blymphocytes are systematically present at very low numbers in peripheral blood of healthy adults, " Leukemia, vol. 25, no. 4, pp. 718-722, 2011.
8. G. E. Marti, A. C. Rawstron, P. Ghia et al., "Diagnostic criteria for monoclonal B-cell lymphocytosis, " British Journal of Haematology, vol. 130, no. 3, pp. 325-332, 2005.
9. Y. K. Shim, R. F. Vogt, D. Middleton et al., "Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population, " Cytometry B-Clinical Cytometry, vol. 72, no. 5, pp. 344-353, 2007.
10. J. M. Rachel, M. L. Zucker, C. M. Fox et al., "Monoclonal B-cell lymphocytosis in blood donors, " British Journal ofHaematology, vol. 139, no. 5, pp. 832-836, 2007.
11. A. C. Rawstron, F. L. Bennett, S. J. M. OConnor et al., "Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia, " The New England Journal of Medicine, vol. 359, no. 6, pp. 575-583, 2008.
12. A. Dagklis, C. Fazi, C. Sala et al., "The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring, " Blood, vol. 114, no. 1, pp. 26-32, 2009.
13. Y. K. Shim, J. M. Rachel, P. Ghia et al., "Monoclonal Bcell lymphocytosis in healthy blood donors: an unexpectedly common finding, " Blood, vol. 123, no. 9, pp. 1319-1326, 2014.
14. D. M. Matos, S. J. Ismael, C. A. Scrideli, F. M. de Oliveira, E. M. Rego, and R. P. Falcao, "Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia, " British Journal of Haematology, vol. 147, no. 3, pp. 339-346, 2009.
15. G. E. Marti, P. Carter, F. Abbasi et al., "B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia, " Cytometry B: Clinical Cytometry, vol. 52, no. 1, pp. 1-12, 2003.
16. A. C. Rawstron, M. R. Yuille, J. Fuller et al., "Inherited predisposition to CLL is detectable as subclinical monoclonal Blymphocyte expansion, " Blood, vol. 100, no. 7, pp. 2289-2291, 2002.
17. T. D. Shanafelt, N. E. Kay, G. Jenkins et al., "B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome, " Blood, vol. 113, no. 18, pp. 4188-4196, 2009.
18. D. Rossi, E. Sozzi, A. Puma et al., "The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors, " British Journal of Haematology, vol. 146, no. 1, pp. 64-75, 2009.
19. L. Scarfo, S. Zibellini, A. Tedeschi et al., "Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines, " Leukemia, vol. 26, no. 7, pp. 1703-1707, 2012.
20. A. C. Rawstron, T. Shanafelt, M. C. Lanasa et al., "Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL), " Cytometry Part B: Clinical Cytometry, vol. 78, supplement 1, pp. S19-S23, 2010.
21. T. D. Shanafelt, P. Ghia, M. C. Lanasa, O. Landgren, and A. C. Rawstron, "Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management, " Leukemia, vol. 24, no. 3, pp. 512-520, 2010.
22. M. C. Lanasa, S. D. Allgood, A. D. Volkheimer et al., "Single-cell analysis reveals oligoclonality among low-countmonoclonal Bcell lymphocytosis, " Leukemia, vol. 24, no. 1, pp. 133-140, 2010.
23. A. Henriques, A. Rodriguez-Caballero, I. Criado et al., "Molecular and cytogenetic characterization of expanded B-cell clones frommulticlonal versusmonoclonal B-cell chronic lymphoproliferative disorders, " Haematologica, vol. 99, no. 5, pp. 897-907, 2014.
24. S. S. Fung, K. L. Hillier, C. S. Leger et al., "Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis, " Leukemia and Lymphoma, vol. 48, no. 6, pp. 1087-1091, 2007.
25. W. Kern, U. Bacher, C. Haferlach et al., "Monoclonal Bcell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL, " British Journal of Haematology, vol. 157, no. 1, pp. 86-96, 2012.
26. T. D. Shanafelt, N. E. Kay, K. G. Rabe et al., "Brief report: natural history of individuals with clinically recognized monoclonal Bcell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia, " Journal of Clinical Oncology, vol. 27, no. 24, pp. 3959-3963, 2009.
27. C. S. Mulligan, M. E. Thomas, and S. P. Mulligan, "Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia, " The New England Journal of Medicine, vol. 359, no. 19, pp. 2065-2066, 2008.
28. T. D. Shanafelt, N. E. Kay, T. G. Call et al., "MBL or CLL:Which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥ 5×109L-1 but a B-cell lymphocyte count < 5×109L-1β" Leukemia Research, vol. 32,no. 9, pp. 14581461, 2008.
29. S. Molica, M. Gentile, F. R. Mauro et al., "An increased number of individuals with clinically recognized monoclonal B-cell lymphocytosis characterizes a recent database of chronic lymphocytic leukemiaRai stage 0, " Acta Haematologica, vol. 127, no. 3, pp. 149-151, 2012.
30. S. Molica, F. R. Mauro, M. Molica, I. D. Giudice, and R. Foa, "Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications, " Leukemia and Lymphoma, vol. 53, no. 9, pp. 1660-1665, 2012.
31. A. C. Rawstron, "Monoclonal B-cell lymphocytosis, " Hematology, pp. 430-439, 2009.
32. J. Moreira, K. G. Rabe, J. R. Cerhan et al., "Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls, " Leukemia, vol. 27, no. 1, pp. 136-141, 2013.
33. C. Fazi, L. Scarfo, L. Pecciarini et al., "General population lowcountCLL-likeMBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL, " Blood, vol. 118, no. 25, pp. 6618-6625, 2011.
34. A. Vardi, A. Dagklis, L. Scarfo et al., "Immunogenetics shows that not allMBL are equal: the larger the clone, themore similar to CLL, " Blood, vol. 121, no. 22, pp. 4521-4528, 2013.
35. A. Henriques, A. Rodriguez-Caballero, W. G. Nieto et al., "Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia, " PLoS ONE, vol. 8, no. 7, Article ID e67751, 2013.
36. P. Ghia, G. Prato, S. Stella, C. Scielzo, M. Geuna, and F. Caligaris-Cappio, "Age-dependent accumulation of monoclonal CD4+CD8 +double positive T lymphocytes in the peripheral blood of the elderly, " British Journal of Haematology, vol. 139, no. 5, pp. 780-790, 2007.
37. A. W. Hauswirth, J. Almeida, W. G. Nieto et al., "Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets, "The American Journal of Hematology, vol. 87, no. 7, pp. 721-724, 2012.
38. U. Randen, A. M. Tierens, G. E. Tjonnfjord, and J. Delabie, "Bone Marrow histology in monoclonal b-cell lymphocytosis shows various b-cell infiltration patterns, "TheAmerican Journal of Clinical Pathology, vol. 139, no. 3, pp. 390-395, 2013.
39. M. C. Lanasa, S. D. Allgood, S. L. Slager et al., "Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL, " Leukemia, vol. 25, no. 9, pp. 1459-1466, 2011.
40. S. Quijano, A. Lopez, A. Rasillo et al., "Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic Bcells in chronic lymphocytic leukemia, " Cytometry B-Clinical Cytometry, vol. 74, no. 3, pp. 139-149, 2008.
41. P. Ghia and F. Caligaris-Cappio, "Monoclonal B-cell lymphocytosis: right track or red herring?" Blood, vol. 119, no. 19, pp. 4358-4362, 2012.
42. P. Ghia, F. Melchers, andA. G. Rolink, "Age-dependent changes in B lymphocyte development inman andmouse, " Experimental Gerontology, vol. 35, no. 2, pp. 159-165, 2000.
43. A. Agathangelidis, N. Darzentas, A. Hadzidimitriou et al., "Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies, " Blood, vol. 119, no. 19, pp. 4467-4475, 2012.
44. D. Casabonne, J. Almeida, W. G. Nieto et al., "Common infectious agents andmonoclonal B-cell lymphocytosis: a crosssectional epidemiological study among healthy adults, " PLoS ONE, vol. 7, no. 12, Article IDe52808, 2012.
45. L. A. Anderson, O. Landgren, and E. A. Engels, "Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia, " British Journal of Haematology, vol. 147, no. 4, pp. 444-449, 2009.
46. G. Fabbri, S. Rasi, D. Rossi et al., "Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation, " Journal of ExperimentalMedicine, vol. 208, no. 7, pp. 1389-1401, 2011.
47. D. Rossi, A. Bruscaggin, V. Spina et al., "Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness, " Blood, vol. 118, no. 26, pp. 6904-6908, 2011.
48. D. Rossi, M. Fangazio, S. Rasi et al., "Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wildtype chronic lymphocytic leukemia, " Blood, vol. 119, no. 12, pp. 2854-2862, 2012.
49. M. Greco, D. Capello, A. Bruscaggin et al., "Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis, " Hematological Oncology, vol. 31, no. 1, pp. 54-55, 2013.
50. R. Foa, I. del Giudice, A. Guarini, D. Rossi, and G. Gaidano, "Clinical implications of the molecular genetics of chronic lymphocytic leukemia, " Haematologica, vol. 98, no. 5, pp. 675-685, 2013.
51. M. Lionetti, S. Fabris, G. Cutrona et al., "High-throughput sequencing for the identification ofNOTCH1mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications, " British Journal of Haematology, vol. 165, no. 5, pp. 629-639, 2014.
52. G. A. Calin, M. Ferracin, A. Cimmino et al., "A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia, " The New England Journal of Medicine, vol. 353, no. 17, pp. 1793-1801, 2005.
53. A. Ferrajoli, T. D. Shanafelt, C. I. Masayoshi Shimizu et al., "Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia, " Blood, vol. 122, pp. 1891-1899, 2013.
54. A. Henriques, A. Rodriguez-Caballero, I. Criado et al., "Molecular and cytogenetic characterization of expanded B-cell clones frommulticlonal versusmonoclonal B-cell chronic lymphoproliferative disorders, " Haematologica, vol. 99, no. 5, pp. 897-907, 2014.
55. G. A. Pangalis, V. A. Boussiotis, and C. Kittas, "Malignant disorders of small lymphocytes: small lymphocytic lymphoma, lymphoplasmacytic lymphoma, and chronic lymphocytic leukemia: their clinical and laboratory relationship, "TheAmerican Journal of Clinical Pathology, vol. 99, no. 4, pp. 402-408, 1993.
56. M. Stetler-Stevenson, "Monoclonal B-cell lymphocytosis in donors, " Blood, vol. 123, pp. 1281-1282, 2014.
57. J. J. Castillo, S. Dalia, and S. K. Pascual, "Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies, " Blood, vol. 116, no. 16, pp. 2897-2907, 2010.
58. N. M. Hardy, C. Grady, R. Pentz et al., "Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation, " British Journal of Haematology, vol. 139, no. 5, pp. 824-831, 2007.
59. W. G. Nieto, C. Teodosio, A. Lopez et al., "Primary Health Care Group of Salamanca for the Study of MBL: non-CLLlikemonoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics, " Cytometry Part B: Clinical Cytometry, vol. 78, supplement 1, pp. S24-S34, 2010.
60. D. Amato, D. G. Oscier, Z. Davis et al., "Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5-monoclonal B-cell lymphocytosis, " The American Journal of Clinical Pathology, vol. 128, no. 2, pp. 333-338, 2007.
61. C. Kalpadakis, G. A. Pangalis, S. Sachanas et al., "Primary bone marrow marginal zone lymphoma (PBMMZL): a new disease entity?" Haematologica, vol. 95, no. 2, p. 109, 2010.
62. C. Kalpadakis, G. Pangalis, S. Sachanas et al., "Comparative study of splenic marginal zone lymphoma (SMZL) and primary bone marrow MZL (PBMMZL), " Haematologica, vol. 96, no. 2, p. p392, 2011.
63. C. Kalpadakis, G. A. Pangalis, T. P. Vassilakopoulos et al., "CD5-monoclonal B-cell lymphoproliferation (MBL): clinical characteristics and outcome, " Haematologica, vol. 97, no. s1, p. p86, 2012.
64. F. Berger, P. Felman, C. Thieblemont et al., "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients, " Blood, vol. 95, no. 6, pp. 1950-1956, 2000.
65. A. Xochelli, C. Kalpadakis, A. Gardiner et al., "Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistentwith amarginal-zone origin: is this a distinct entity?" Blood, vol. 123, no. 8, pp. 1199-1206, 2014.